215 related articles for article (PubMed ID: 32046149)
1. Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of
Kardan-Yamchi J; Kazemian H; Battaglia S; Abtahi H; Foroushani AR; Hamzelou G; Cirillo DM; Ghodousi A; Feizabadi MM
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32046149
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
Puyén ZM; Santos-Lázaro D; Vigo AN; Coronel J; Alarcón MJ; Cotrina VV; Moore DAJ
BMC Infect Dis; 2022 Aug; 22(1):705. PubMed ID: 36002805
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in China.
He W; Liu C; Liu D; Ma A; Song Y; He P; Bao J; Li Y; Zhao B; Fan J; Cheng Q; Zhao Y
J Glob Antimicrob Resist; 2021 Sep; 26():241-248. PubMed ID: 34214699
[TBL] [Abstract][Full Text] [Related]
4. Prediction of drug resistance profile of multidrug-resistant Mycobacterium tuberculosis (MDR-MTB) isolates from newly diagnosed case by whole genome sequencing (WGS): a study from a high tuberculosis burden country.
Sun W; Gui X; Wu Z; Zhang Y; Yan L
BMC Infect Dis; 2022 May; 22(1):499. PubMed ID: 35624432
[TBL] [Abstract][Full Text] [Related]
5.
Rukmana A; Gozali C; Erlina L
Int J Microbiol; 2024; 2024():2037961. PubMed ID: 38469390
[TBL] [Abstract][Full Text] [Related]
6. Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea.
Yang JS; Kim KJ; Choi H; Lee SH
Ann Lab Med; 2018 Nov; 38(6):563-568. PubMed ID: 30027700
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Whole-Genome Sequence Method to Diagnose Resistance of 13 Anti-tuberculosis Drugs and Characterize Resistance Genes in Clinical Multi-Drug Resistance
Chen X; He G; Wang S; Lin S; Chen J; Zhang W
Front Microbiol; 2019; 10():1741. PubMed ID: 31417530
[No Abstract] [Full Text] [Related]
8. Analysis of Drug-Resistance Characteristics and Genetic Diversity of Multidrug-Resistant Tuberculosis Based on Whole-Genome Sequencing on the Hainan Island, China.
Wang J; Yu C; Xu Y; Chen Z; Qiu W; Chen S; Pei H; Zhong Y
Infect Drug Resist; 2023; 16():5783-5798. PubMed ID: 37692467
[TBL] [Abstract][Full Text] [Related]
9. [Detection of tuberculosis genes associated with drug-resistance in paraffin-embedded tissue specimens using next generation sequencing technology].
Song J; Zhang ZG; Dong YJ; Du WL; Wang YX; Liu ZC; Li K; Zhang Q; Sun Q; Che NY
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):234-241. PubMed ID: 32164095
[No Abstract] [Full Text] [Related]
10. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of extensive drug resistance in multidrug resistance tuberculosis isolates].
Bektöre B; Haznedaroğlu T; Baylan O; Ozyurt M; Ozkütük N; Satana D; Cavuşoğlu C; Seber E
Mikrobiyol Bul; 2013 Jan; 47(1):59-70. PubMed ID: 23390903
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
[TBL] [Abstract][Full Text] [Related]
13. Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan.
Ali A; Hasan Z; McNerney R; Mallard K; Hill-Cawthorne G; Coll F; Nair M; Pain A; Clark TG; Hasan R
PLoS One; 2015; 10(2):e0117771. PubMed ID: 25719196
[TBL] [Abstract][Full Text] [Related]
14. Whole genome sequencing-based drug resistance predictions of multidrug-resistant
Mbelele PM; Utpatel C; Sauli E; Mpolya EA; Mutayoba BK; Barilar I; Dreyer V; Merker M; Sariko ML; Swema BM; Mmbaga BT; Gratz J; Addo KK; Pletschette M; Niemann S; Houpt ER; Mpagama SG; Heysell SK
JAC Antimicrob Resist; 2022 Apr; 4(2):dlac042. PubMed ID: 35465240
[TBL] [Abstract][Full Text] [Related]
15. Whole-genome sequencing analysis of multidrug-resistant
Tania T; Sudarmono P; Kusumawati RL; Rukmana A; Pratama WA; Regmi SM; Kaewprasert O; Chaiprasert A; Chongsuvivatwong V; Faksri K
J Med Microbiol; 2020 Jul; 69(7):1013-1019. PubMed ID: 32579102
[No Abstract] [Full Text] [Related]
16.
Pang Y; Zong Z; Huo F; Jing W; Ma Y; Dong L; Li Y; Zhao L; Fu Y; Huang H
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739779
[TBL] [Abstract][Full Text] [Related]
17. In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates.
Chandramohan Y; Padmanaban V; Bethunaickan R; Tripathy S; Swaminathan S; Ranganathan UD
J Glob Antimicrob Resist; 2019 Dec; 19():348-353. PubMed ID: 31226332
[TBL] [Abstract][Full Text] [Related]
18. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.
Wu X; Gao R; Shen X; Guo Y; Yang J; Wu Z; Tan G; Wang H; Yu F
Int J Infect Dis; 2020 Jul; 96():48-53. PubMed ID: 32339720
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of genetic correlation with fluoroquinolones resistance in rifampicin-resistant Mycobacterium tuberculosis isolates.
Teng C; Li L; Su D; Li H; Zhao B; Xia H; Teng H; Song Y; Zheng Y; Cao X; Zheng H; Zhao Y; Ou X
Heliyon; 2024 Jun; 10(11):e31959. PubMed ID: 38868072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
